A. Aisling, a Delaware limited partnership formed on August 25, 2015, is an investment adviser located in New York, NY. Aisling’s general partner is Aisling Capital Partners IV LLC, a Delaware limited liability company (the “General Partner”). Aisling is principally owned by its two co-presidents, Andrew N. Schiff and Steven A. Elms. B. As an investment adviser, Aisling provides investment advisory services to pooled investment vehicles, Aisling Capital IV, LP and Aisling Capital V, LP (together with any other private investment funds managed by Aisling, including future funds, the “Funds” and each, a “Fund”), as well as co-investment vehicles formed in connection therewith. The Funds are exempt from registration under the Investment Company Act of 1940, as amended (the “Investment Company Act”), pursuant to Section 3(c)(7) of the Investment Company Act. The general partner of Aisling Capital IV, LP is Aisling Capital Partners IV, LP, a Delaware limited partnership, and the general partner of Aisling Capital V, LP is Aisling Capital Partners V, LP, a Delaware limited partnership (each a “Fund GP” and together, the “Fund GPs”). The Fund GPs and Aisling are affiliates. The Fund GPs are registered under the Advisers Act pursuant to Aisling’s registration in accordance with SEC guidance. This Brochure also describes the business practices of the Fund GPs, which operate as a single advisory business together with Aisling. Aisling provides discretionary investment management services to the Funds pursuant to each Fund’s respective investment management agreement with Aisling. Aisling manages the assets of the Funds in accordance with the limited partnership agreement (“Partnership Agreement”) for each Fund, the Confidential Private Placement Memorandum (“PPM”) for each Fund and related agreements (together with the Partnership Agreement and PPM, are referred to herein as the “Offering Documents”). The Firm’s investment objective is to make investments in companies developing and commercializing important and innovative healthcare products, services and technologies, across a range of financial instruments. The Firm pursues a multi-strategy investment approach, and may invest in private companies, public companies, equity, debt and other structured securities. The Firm generally seeks to make non-control investments. Information about Aisling’s advisory services is included in this Brochure

and is qualified in its entirety by information contained in the relevant Fund’s Offering Documents. C. Aisling does not tailor its advisory services to the individual or particular needs of investors in the Funds. Such investors accept the terms of advisory services as set forth in the relevant Offering Documents. The Firm has broad investment authority with respect to the Funds and, as such, investors should consider whether the investment objectives of a Fund will be in line with their respective individual objectives and risk tolerance prior to investment. The Funds or the general partners of such Funds have entered and may in the future enter into side letters or other written agreements with certain investors that have the effect of establishing rights or provisions under, or altering or supplementing, the terms of a Fund’s partnership agreement or an investor’s subscription agreement with respect to such investor. Such provisions have included and may include, without limitation, rights with respect to fees, expenses, disclosure or priority on co-investment opportunities, distributions, excuse or exclusion from investments, transfers of interests in the Fund, tax and other reporting, notice requirements, sharing of investment ideas, introductions to business persons and opportunities, and other representations, warranties or diligence confirmations. Other side letter rights are likely to confer benefits on the relevant investor at the expense of the relevant Fund or of investors as a whole, including in the event that a side letter confers additional reporting, information rights and/or transfer rights, the costs and expenses of which are expected to be borne by the relevant Fund. These additional rights will have the effect of increasing the expenses borne by the relevant Fund and/or its investors not party to the particular side letter. For the most part, any rights established, or any terms altered or supplemented will govern only the investment of the specific investor and not the terms of a Fund as whole. Certain additional rights but not all rights, terms or conditions could be elected by certain sizeable investors with “most favored nations” rights pursuant to a Fund’s limited partnership agreement. D. Aisling does not participate in wrap fee programs. E. As of December 31, 2023 Aisling had assets under discretionary management of approximately $515,733,599.